convergent extension ͉ Looptail mice ͉ planar cell polarity ͉ mutant mouse N eural tube defects (NTDs) constitute one of the most common congenital abnormalities in humans, occurring in 1 per 1,000 live births (1) . NTDs range across a spectrum of pathologies, from very benign closed spinal dysraphisms, such as dermal sinus, to the severe open dysraphisms, such as myelomeningocele, cephalocele, and craniorachischisis (2, 3) . The molecular mechanisms underlying NTDs are complex, with both genetic and environmental contributions. NTDs behave as a complex trait with genetic heterogeneity, incomplete penetrance, and expressivity further modulated by environmental factors, including perinatal supplementation with folic acid (1, 4) , all likely to contribute to the wide spectrum of disease. The study of mouse mutants with NTDs has proven useful to identify molecular pathways involved in the complex process of neurulation (5). Looptail (Lp) is a semidominant mutation in which Lp/ϩ heterozygotes display urogenital defects and a characteristic ''looped'' tail. Lp/Lp homozygotes die in utero of a severe NTD, craniorachischisis, a condition in which the neural tube fails to initiate closure and remains completely open from midbrain to tail (6) . Additional defects in Lp/Lp embryos are noticed in the inner ear (organization of hair cells of the cochlea) and the heart (outflow tract defects) (7, 8) . Lp is caused by mutations in Vangl2 (9, 10), a gene that codes for a fourtransmembrane domain membrane protein (9, 11) . During development, Vangl2 is expressed along the neural tube at the time of closure, from the midbrain/hindbrain boundary to its mostcaudal extent, decorating the entire neuroepithelial dorsalventral axis, including floor plate cells (9, 10, 12) .
Vangl2 belongs to a group of highly conserved planar cell polarity (PCP) proteins initially discovered in Drosophila (13) (14) (15) . They include the membrane proteins Frizzled and Van Gogh and the cytoplasmic proteins Dishevelled and Prickle that form membrane-bound signaling complexes (16) (17) (18) (19) (20) (21) (22) (23) (24) . Lp-associated Vangl2 mutations (Vangl2 E255D , Vangl2  S464N ) map to the cytoplasmic domain of the protein and abrogate interaction of Vangl2 with Dishevelled (Dvl) (25) . Studies of mutants of vertebrate PCP genes show that PCP genes play a role in convergent extension (CE) movements. CE is the process by which cells move mediolaterally and intercalate with each other, causing remodeling of a tissue or epithelium with narrowing in one axis and lengthening in a perpendicular axis. CE plays a role during gastrulation and neurulation and is responsible for narrowing and lengthening the neural plate during neural tube closure (26) (27) (28) (29) (30) . In mice, PCP failure causes severe NTD, including that detected in Lp embryos.
Vertebrates have a second Vangl gene, Vangl1. Vangl1 and Vangl2 proteins share Ϸ70% similarity, including identical predicted secondary structures. This structural similarity underlies conserved function: Vangl1 and Vangl2 proteins bind to three mammalian Dvl proteins, and Lp mutations engineered in Vangl1 or Vangl2 abrogate interaction with Dvl (25) . Likewise, ectopic expression of the zebrafish Vangl1 relative partly suppress the gastrulation defect of tri (Vangl2) mutants (31) . Although little is known about the role of Vangl1 during development, we have identified independent mutations (V239I, R274Q, M328T) in the human VANGL1 gene in sporadic and familial cases of NTDs (32) . The mutations are patient-specific and affect residues highly conserved in the evolution of the Vangl family. VANGL1 V239I is a de novo mutation in a familial setting that abrogates interaction between VANGL1 and members of the Dishevelled family (32) . As opposed to the mouse, in which homozygosity for loss-of-function mutations at PCP genes (including Vangl2) is both necessary and sufficient for craniorachischisis, human NTD patients have been found to be heterozygote for VANGL1 mutations. This suggests that these mutations are either dominant negative, cause loss-of-function in a gene dosage-dependent pathway, or may be modulated by lesions at other genetic loci or environmental conditions. To better characterize the role of Vangl1 during embryogenesis and in the etiology of NTDs, we created and studied a mouse mutant bearing a disrupted Vangl1 gene.
Results
Vangl1 Mutant Mouse Line. We identified a mutant embryonic stem cell line (Vangl1 gt ) carrying a ␤-Geo gene-trap cassette (␤-gal and neomycin phosphotransferase fusion) inserted into intron 3 of Vangl1 (GenBank accession no. NC000069) 237 nucleotides downstream of the exon 3 donor-splice site (Fig. 1A) . The transcript expressed by the targeted Vangl1 allele is predicted to code for a severely truncated nonfunctional protein consisting of 63 aa of the N-terminal cytoplasmic portion fused to ␤-gal. The Vangl1 gt targeted allele was verified by Southern blotting of EcoRV digested DNA (WT allele, 8.8 kb; mutant, 13.5 kb, 3.2 kb) (Fig. 1B) . RT-PCR amplification was used to demonstrate expression of both WT and mutant transcripts at a similar level in Vangl1 gt/ϩ heterozygote mice, whereas only mutant transcripts were detected in Vangl1 gt/gt homozygotes (Fig.  1C) . We also tested the possibility that normal splicing of intron 3 might occur in the targeted allele causing excision of the ␤-Geo cassette and production of WT Vangl1 mRNA. In a panel of homozygote Vangl1 gt/gt embryos, a very low level of WT Vangl1 transcript (Ͻ5% of total) was noted by RT-PCR in one animal [supporting information (SI) Fig. 7 Expression of Vangl1 During Early Development. Production of Vangl1/␤-gal fusion by the targeted allele permits evaluation of Vangl1 expression during development. We first examined the pattern of Vangl1 transgene expression in neurulating embryos (Fig. 2 ). X-Gal staining faithfully recapitulated the expression of endogenous Vangl1 protein (detected with anti-Vangl1 antibody) in the floor plate and the notochord (Fig. 2 A, D, I , and L). In embryonic day (E)8.0 to E8.5 embryos, a dynamic pattern of X-gal staining was noted along the rostrocaudal axis ( Fig. 2 
B, C, and E-H).
In all sections, Vangl1:␤-gal was expressed in the floor plate cells and in the notochord. In rostral hindbrain, strong X-gal staining was noted in the ventral ventricular zone ( (Fig. 2M ). However, Vangl1:␤-gal expression remained strong in the notochord, where it persisted through E13.5 ( Fig. 2N) . At E9.5, Vangl1:␤-gal expression began to appear outside of the neuroepithelium, notably in the heart ( (Fig. 3) , as we described previously (25) . Whereas Vangl1 expression was restricted to the midline floor plate cells and to the notochord ( Fig. 3 A and D) , Vangl2 was more widely distributed over the entire neuroepithelium (including some of the Vangl1-positive cells in the floor plate cells) but was absent from the notochord ( Fig. 3 B and E) . The identity of notochord and floor plate cells was confirmed by staining with the marker Foxa2 ( Fig. 3 C and F) . Together, these results show Vangl1 gt/gt embryos; transverse sections (magnification, ϫ400). (O and P) X-Gal staining of myocardial cells of heart (O) and epithelium of mesonephric duct (P). fp, floor plate; dnt, dorsal neural tube; h, heart; hl, hindlimb; md, mesonephric duct; nd, notochord; nt, neural tube; ps, primitive streak; rp, roof plate; sm, somites; vnt, ventral neural tube.
that Vangl1 mRNA and proteins are expressed in the developing neural tube. (Fig. 4 C and D) . In Fig. 4 E and F Vangl2 lp/؉ Embryos. In addition to craniorachischisis, PCP mutants display a characteristic planar cell polarity defect in the orientation of stereociliary bundles in hair cells of the organ of Corti (7, (33) (34) (35) . We detected Vangl1 and Vangl2 protein expression in the organ of Corti (SI Fig. 8 (Fig. 5 B and C) . At the base of the cochlear duct, 20% of the inner hair cells (IHCs) were misoriented (compared with 70% in Vangl2 lp/lp tissues). Misorientation of all three outer hair cell (OHC) layers was seen in compound heterozygotes, particularly at the apical turn: Ͼ50% in OHC1, 65% in OHC2, and Ͼ80% in OHC3. The stereociliary vertices were randomly oriented, with rotation angles of o , similar to Vangl2 lp/lp cochleas. Therefore, Vangl1 and Vangl2 genetically interact to regulate planar polarity in the inner ear, including orientation of stereociliary bundles, extension of cochlear ducts, and thinning of cell layers that position hair cells in organized rows. lp/ϩ embryos identified an aberrant right subclavian artery, which was confirmed by 3D reconstruction analysis as compared with WT ( Fig. 6 G and F) . The same extracardiac phenotype was evident in Vangl2 lp/lp embryos (Fig. 6D) . The right subclavian artery originates from the fourth aortic arch, which itself is derived from the posterior-medial aspect of the distal aortic arch. We identified X-gal/Vangl1 staining in the fourth aortic arch (Fig. 6A) lp/ϩ double heterozygotes identified a striking set of abnormalities, which included (i) craniorachischisis, (ii) severe misorientation of cochlear stereociliary bundles (both similar to Vangl2 lp/lp ), and (iii) a cardiac defect in the form of aberrant right subclavian arteries. NTDs are a heterogeneous set of conditions ranging from very benign to very severe and lethal in utero. Although, a clear genetic component to NTD has been documented, this genetic contribution is complex and multigenic, with further modulation of penetrance and expressivity by additional genetic loci and environmental factors (1) . Recently, we identified mutations (V239I, R274Q, M328T) in the human VANGL1 gene in a cohort of 165 patients representing sporadic and familial cases of NTDs. Two of these variants (V239I, M328T) were shown to cause partial or complete loss of VANGL1 function in complementation studies in zebrafish and Dvl protein interactions in yeast (32) . The observations that (i) only a small proportion of NTD patients examined harbored mutations in VANGL1, (ii) all mutations in NTD patients were detected as heterozygotes, and (iii) patients with the same de novo mutation (V239I) showed different disease severity in a familial setting suggest heterogeneity in the genetic components of NTDs in humans with incomplete penetrance of VANGL1 mutations. These findings further suggest that in addition to VANGL1 mutations, environmental factors and/or sensitizing genetic lesions play an important role in the etiology of NTDs in humans. Results from the present study demonstrate that partial loss of VANGL2 function could be one such sensitizing event.
Cardiac Defects in Compound
Although Vangl1 gt/ϩ ;Vangl2 lp/ϩ double heterozygotes display craniorachischisis similar to that of Vangl2 lp/lp , the absence of a neural tube phenotype in Vangl1 gt/gt is puzzling. Genetic interactions between Vangl2 and other PCP genes such as Ptk7 and Scribble have been shown to cause NTD and inner ear phenotypes in double heterozygotes, but homozygosity for loss-of-function alleles at each of these two loci also causes severe craniorachischisis (38, 39) . Whether Vangl1 genetically interacts with other PCP genes is unknown. Our results suggest a different type of functional relationship between Vangl1 and Vangl2. We propose that the Vangl pathway is exquisitely sensitive to gene dosage during NT formation, with a minimum threshold level of combined Vangl activity required for neural tube closure. We further suggest that Vangl1 and Vangl2 have redundant function. In cells that express abundant levels of Vangl2 compared with Vangl1, Vangl2 may play a seemingly ''dominant'' role. In this scenario, loss of 50% of Vangl2 puts the pathway in a ''sensitized'' mode eliciting a phenotype from partial loss of Vangl1. In cells with high levels of Vangl2, loss of Vangl1 may be completely masked or may have a subtle effect (e.g., misorientation of cochlear stereociliary bundles). This model is compatible with the observations that the PCP pathway is highly gene-dosage-dependent, with both loss-offunction mutations and overexpression of individual PCP members resulting in the same deleterious phenotype. Finally, in view of the observation that VANGL1 mutations in human cases of NTDs were heterozygote, it is tempting to speculate that these do not behave as dominant negative or gain-offunction mutations but rather as partial loss of function in a gene-dosage-dependent pathway that can be further enhanced or attenuated by polymorphic variants at other loci and/or environmental inf luences. This proposal is also compatible with the broad spectrum of severity and phenotypic manifestations of NTDs in humans.
In conclusion, our observations strongly suggest that VANGL1 functions in the mammalian PCP pathway, acting in concert with VANGL2 to control neural tube formation, orientation of the stereociliary bundles in cochlea, and organization of major extracardiac vessels. Genotyping. The Vangl1 gt allele was detected by EcoRV digestion of genomic DNA and Southern blotting by using a 601bp Vangl1 cDNA probe generated by RT-PCR by using primer pairs Vangl1-Ex3-F (5Ј-AGAACAAGAGAAAGACA-CAAATCAC-3Ј) and mVangl1-Ex4-R (5Ј-CTGCGTATTGCACGATGTCC-3Ј). PCR genotyping was done by using three primers in one reaction: mVangl1-Ex3-F and either Vangl1-In3-R2 (5Ј-CACCAGATTTCCATGCTTGCCA-3Ј) (744-bp WT fragment) or GT1-R (5Ј-CATACTTTCGGTTCCTCTTCCCATG-3Ј) (410-bp mutant fragment). The Vangl2 S464N Lp allele was identified by amplification of exon 8 by using primers mVangl2-Ex8-F (5Ј-ACCTTAGAAACACCCTAGCT-3Ј) and mVangl2-Ex8-R (5Ј-ACAGAGGTCTCCGACTGCAGC-3Ј), followed by nucleotide sequencing.
Materials and Methods

Generation
RNA Preparation and RT-PCR.
cDNA was synthesized from RNA by using Maloney murine leukemia virus reverse transcriptase and used to amplify fragments corresponding to either WT (Vangl1; 601 bp) or fusion transcript (Vangl1-␤-Geo; 378 bp), with primers Vangl1-Ex3-F/mVangl1-Ex4-R (WT) and mVangl1-Ex3-F/Pr2-Geo (5Ј-ATTCAGGCTGCGCAACTGTTGGG-3Ј) (mutant).
Histology and Immunohistochemistry. Whole-mount staining for ␤-gal activity was done as described (12) . Images from 12-m X-gal-stained cryosections were acquired by using the AxioVision 4.3 software package (Zeiss). Rabbit anti-Vangl1 and anti-Vangl2 antisera (1:200 and 1:50) (25), mouse anti-Foxa2 (1:20, Developmental Studies Hybridoma Bank, University of Iowa), Cy3-conjugated goat anti-rabbit (Jackson ImmunoResearch), and Alexa Fluor 488-conjugated goat anti-mouse (Invitrogen) were used for immunofluorescence on cryosections. For histology, 5-m serial sections of fixed embryos or microdissected hearts were stained with hematoxylin/phloxin/saffron. Threedimensional reconstructions were created by using Amira4.1 software (Mercury Computer Systems) as described previously (40) .
Whole-Mount Inner Ear Preparations and Analysis of the Stereocilia Rotation.
Cochleas from E18.5 embryos were fixed in 4% paraformaldehyde, microdissected, and incubated with anti-myosin VIIa antibody (1:500; Proteus Biosciences Inc) and Alexa Fluor 488-conjugated phalloidin (1:40), followed by Cy3-conjugated goat anti-rabbit antibody (1:200). The orientation of stereocilia was determined as described (7) . A minimum of 40 cells per region per embryo were counted. The stereociliary bundle orientation was determined in relation to a line perpendicular to the pillar cells; cells with a rotation degree of more than 30 in either direction from the perpendicular line were considered misoriented (7) .
